Unlock Multi-Omics
Solutions That Scale
Join us at American Association for Cancer Research® (AACR) Annual Meeting 2025 I Booth 1445
Translating scientific discoveries from bench to bedside
to drive progress in cancer research
Our high-content solutions in serum, spatial and single-cell proteomics
and multi-omics offer the highest levels of content, precision andunique scalability in the life science industry.
Exclusive speaker panel session
Lost in Omics? Navigating the Path from Protein Discovery to Healthcare Impacts
Monday, April 28 | 12:30–1:30 pm | Spotlight Theater D
Lost in Omics? Navigating the Path from Protein Discovery to Health Care Impacts
Monday, April 28th | 12:30 – 1:30 pm | Spotlight Theater D
What you'll gain
- Expert insights on leveraging proteomics in clinical applications
- Knowledge on overcoming challenges in biomarker discovery
- Networking opportunities with top researchers
Join us at American Association for Cancer Research® (AACR) Annual Meeting 2025 - Booth 1445
Discover scalable multi-omics solutions transforming cancer research and precision medicine. Connect with experts, explore cutting-edge innovations, and see how we’re translating discoveries into real-world impact.
See our poster sessions
Monday, April 28 and Tuesday, April 29
Monday, April 28
9:00am–12:00pm
- Enabling Sensitivity, Repeatability and Reproducibility Required for Immuno-Oncology Research on the CyTOF XT PRO Mass Cytometer
- Spatial Profiling of Exhausted T cells Using High-Plex Imaging Mass Cytometry™
- A 50-Marker Mass Cytometry Intracellular Cytokine Staining Panel: Unprecedented Resolution Enables Unrivaled Detection of Functional Diversity Present Among Human Immune Cell Subsets
- Implementation of a Novel Immune Monitoring Strategy for Multicenter Clinical Trials to Enable Equity in Cancer Prognosis for Individuals From Remote Settings of Australia
- An Automated and Scalable Pipeline for High-Dimensional Immune Cell Phenotyping in Mass Cytometry Datasets
- A Deep-Learning Approach for Tissue Mapping and Cell Phenotyping in Imaging Mass Cytometry Data Analysis
- Flexible and Comprehensive Phenotyping of Tumor and Peripheral Blood Mononuclear Cells in Endometrial Carcinoma
2:00pm–5:00pm
- Advancing CAR T Clinical Development with High-Parameter CyTOF Technology
- Imaging Mass Cytometry Detects the True Dynamic Range of Low-Abundance Biomarker Expression in Human Tumors
Tuesday, April 28
9:00am–12:00pm
- Application of a Comprehensive Multi-Omic Immune Profiling Strategy Achieves Superior Checkpoint Immunotherapy Response Prediction in Lung Cancer
2:00pm–5:00pm
- Expansion of the Known Functional Diversity of Human T Cells Achieved Due to the Unprecedented Resolution of Intracellular Proteins by Mass Cytometry (CyTOF)
Wednesday, April 30
9:00am–12:00pm
- Accelerating Immuno-Oncology Research with Flexible Workflows Using Modular Flex-Fit™ Panels
Defining standards
Our industry-leading proteomic and multi-omic solutions that scale
Every marker, all at once
Our industry-leading proteomic and multi-omic solutions
that scale
High-resolution spatial proteomics
Highest dynamic range and througput
Ultrahigh-plex precision proteomics
Enable 11,000 protein measurements with unparalleled reproducibility
High-thoroughput genomic profiling
The only hands-free, walk away qPCR system
Interested in talking with an expert?
Unless explicitly and expressly stated otherwise, all products are provided for Research Use Only, not for use in diagnostic procedures. Find more information here.
Not affiliated with or endorsed by American Association for Cancer Research® (AACR) Annual Meeting 2025.